Cytosorbents (NASDAQ:CTSO) versus Electromed (NYSE:ELMD) Head to Head ComparisonDefense World · Oct 11, 2026
Squarepoint Ops LLC Purchases Shares of 19,498 Electromed, Inc. $ELMDDefense World · Sep 19, 2026
Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main EventBusiness Wire · Sep 9, 2026
Electromed: Contrarian 'Buy' With SmartVestSeeking Alpha · Aug 28, 2026
Electromed, Inc. (ELMD) Q4 2026 Earnings Call TranscriptSeeking Alpha · Aug 25, 2026
Electromed, Inc. (ELMD) Surpasses Q4 Earnings EstimatesZacks Investment Research · Aug 25, 2026Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 25, 2026 | $0.32 | $0.39 | Beat |
| May 12, 2026 | $0.26 | $0.35 | Beat |
| Feb 10, 2026 | $0.27 | $0.32 | Beat |
| Nov 12, 2025 | $0.22 | $0.25 | Beat |
| Aug 26, 2025 | $0.22 | $0.25 | Beat |
| May 13, 2025 | $0.20 | $0.21 | Beat |